Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland
- PMID: 17470647
- PMCID: PMC1932552
- DOI: 10.1128/AAC.01614-06
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland
Abstract
The epidemiology of clavulanic acid-inhibited extended-spectrum beta-lactamases (ESBLs) was investigated among infection-associated enterobacterial isolates at the University Hospital in Lausanne, Switzerland, from January 2004 to June 2005. Out of 57 nonrepetitive ESBL producers (prevalence rate of 0.7%), 45 produced CTX-M-like ESBLs. CTX-M enzymes were mostly from clonally nonrelated Escherichia coli isolates, from urinary infections and community-acquired infections. Pediatric patients (20 out of 57) accounted for a large number of CTX-M producers. CTX-M-15 was the most frequent CTX-M-type enzyme. The plasmid-located bla(CTX-M) genes were associated with either ISEcp1 or ISCR1 insertion sequences. This study is the first published report of CTX-M-type beta-lactamases in Switzerland.
Figures
References
-
- Al Naiemi, N., A. Bart, M. D. de Jong, C. M. Vandenbroucke-Grauls, P. J. Rietra, Y. J. Debets-Ossenkopp, P. C. Wever, L. Spanjaard, A. J. Bos, and B. Duim. 2006. Widely distributed and predominant CTX-M extended-spectrum β-lactamases in Amsterdam, The Netherlands. J. Clin. Microbiol. 44:3012-3014. - PMC - PubMed
-
- Brigante, G., F. Luzzaro, M. Perilli, G. Lombardi, A. Coli, G. M. Rossolini, G. Amicosante, and A. Toniolo. 2005. Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int. J. Antimicrob. Agents 25:157-162. - PubMed
-
- Bruderer, T., M. Jutzi, H. Adler, and R. Frei. 2006. The CTX-M is the most predominant group of extended-spectrum β-lactamases (ESBL) in Switzerland, p. 130. Swiss Soc. Microbiol. 65th Annu. Assembly. Lausanne, Switzerland, 7 and 8 March 2006.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
